India's Dr. Reddy's Laboratories (RDY) recalls 13,560 bottles of metoprolol succinate, a drug for high blood pressure, after it failed a dissolution test, a measure to check the amount of time it takes the active ingredient to release into the body which helps predict the drug's performance inside the body. The FDA classifies the recall as Class II which means that use or exposure may cause temporary or medically reversible health consequences.
Metoprolol succinate extended release is a generic form of AstraZeneca's (AZN) Toprol XL. Wockhardt Ltd recalled 109,744 bottles of the same drug last month also for failing a dissolution test.
In March, Dr. Reddy's recalled 58,656 bottles of the heartburn drug lansoprazole due to microbial contamination. Indian drug makers have been hit by numerous quality issues this year which has prompted increased scrutiny from regulators.